Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Tools & Techniques Immunology, Microbiology, Diagnostics & prognostics

Inside Intestinal Disease

Inflammatory bowel diseases (IBD) are relapsing and remitting chronic conditions of the gut that have a major impact on patients’ quality of life. Current therapeutic approaches aim to reduce symptoms – but their effectiveness varies, and patients may develop tolerances to the drugs. As such, it’s really important to have ways of assessing disease activity to better manage patients. Identifying microbial alterations associated with IBD could provide a diagnostic tool that enables us to spot disease earlier and minimize damage. It also contributes to better understanding of the underlying mechanisms associated with disease pathogenesis, allowing the design of improved therapeutic strategies.

Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

About the Author

Sheena Cruickshank

Sheena Cruickshank is a Senior Lecturer in Immunology at the Faculty of Biology, Medicine and Health, University of Manchester, UK.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register